CD2AP and prostate carcinoma: Although CIN85 has previously been observed in a diffuse pattern in both the cytoplasm and the nucleus in some cells (e.g., in the human prostate carcinoma [PC‐3 U] cells; Yakymovych et al., 2015), we think it is likely that the small amount of CIN85 and CD2AP observed in the nucleus of TaC12 cells is an artefact due to non‐specific antibody labelling, especially considering that ectopically expressed CD2AP/CIN85 was not found in the nucleus.